🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a pilot phase 1b study to investigate the safety and side effects o...
Status
Completed
Location
University of California, San Diego
Start Date
2018-08-15
Trial ID
NCT02776917
Treatments Being Tested
The purpose of this study is to test the safety of a combination of two ant...
Status
Completed
Location
Center for Lymphoid Malignancies at CUMC
Start Date
2008-06
Trial ID
NCT00691210
Treatments Being Tested
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
This is a Phase 1/2, open-label, multicenter study designed to evaluate the...
Status
Unknown
Location
Innovative Clinical Research Institute
Start Date
2021-11-09
Trial ID
NCT05119933
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
Status
Recruiting
Location
Keck Medicine of USC Koreatown
Start Date
2023-08-10
Trial ID
NCT05372640
Gestational trophoblastic neoplasm affect women and is sensitive to chemoth...
Status
Unknown
Location
Mansoura University Hospital
Start Date
2015-09
Trial ID
NCT02606539
Treatments Being Tested
Phase 1/2 trial to study the safety, pharmacokinetics and preliminary effic...
Status
Terminated
Location
The first affiliated hospital, Zhejiang Unviersity school of medicine
Start Date
2022-11-25
Trial ID
NCT05611853
Treatments Being Tested
The advent of immunotherapy (immune checkpoint inhibitors \[ICI\]) has been...
Status
Active Not Recruiting
Location
Beatson West of Scotland Cancer Centre
Start Date
2022-08-30
Trial ID
NCT06597045
Treatments Being Tested
This is a randomized trial for patients with metastatic hormone receptor (H...
Status
Completed
Location
University of Alabama at Birmingham (UAB)
Start Date
2016-03
Trial ID
NCT02632045
Treatments Being Tested
Objectives: To determine maximum tolerated dose of farnesyl transferase in...
Status
Completed
Location
Duke University Health System
Start Date
2005-10
Trial ID
NCT00612651
Treatments Being Tested